Insecticides India Ltd is Rated Sell by MarketsMOJO

1 hour ago
share
Share Via
Insecticides India Ltd is rated Sell by MarketsMojo, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 July 2026, providing investors with the latest insights into the company’s performance and outlook.
Insecticides India Ltd is Rated Sell by MarketsMOJO

Current Rating and Its Significance

MarketsMOJO’s current rating of Sell for Insecticides India Ltd indicates a cautious stance towards the stock. This rating suggests that investors should consider reducing their exposure or avoid initiating new positions at this time. The rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment potential in the pesticides and agrochemicals sector.

Quality Assessment

As of 09 July 2026, Insecticides India Ltd holds an average quality grade. This reflects moderate operational efficiency and business fundamentals. While the company has demonstrated steady net sales growth at an annualised rate of 8.55% over the past five years, this growth is relatively modest compared to industry peers. Operating profit growth has similarly been subdued, registering an annual rate of 8.73%. These figures suggest that while the company maintains a stable business model, it lacks the robust growth dynamics that typically characterise higher-quality stocks.

Valuation Perspective

The stock’s valuation is currently graded as fair. This implies that the market price reasonably reflects the company’s earnings and growth prospects, but does not offer a significant margin of safety or upside potential. Investors should note that the stock’s market capitalisation remains in the smallcap category, which often entails higher volatility and risk. Given the fair valuation, the stock does not present an attractive entry point based on price metrics alone.

Financial Trend Analysis

The financial trend for Insecticides India Ltd is negative as of 09 July 2026. The latest quarterly results for March 2026 reveal a decline in profitability metrics. Profit Before Tax (excluding other income) fell sharply by 40.81% to ₹11.34 crores, while Profit After Tax decreased by 15.7% to ₹11.71 crores. Additionally, the company reported its lowest quarterly PBDIT at ₹25.60 crores. These figures highlight a weakening earnings trajectory, which is a key concern for investors seeking stable or improving financial performance.

Technical Outlook

From a technical standpoint, the stock is currently exhibiting a sideways trend. Price movements over recent periods have been mixed, with a 1-day gain of 1.15% and a 3-month gain of 3.27%, but a notable 1-month decline of 8.83%. Year-to-date, the stock has fallen by 7.23%, and over the past year, it has underperformed significantly with a return of -30.33%. This underperformance is stark when compared to the broader BSE500 index, which itself posted a negative return of -2.30% over the same period. The sideways technical grade suggests limited momentum and a lack of clear directional bias, which may deter momentum-focused investors.

Stock Returns and Market Comparison

As of 09 July 2026, Insecticides India Ltd’s stock returns paint a challenging picture. The stock has delivered a negative 30.33% return over the last year, significantly underperforming the broader market benchmark. This underperformance, despite a generally weak market environment, underscores the company’s relative weakness within its sector and the broader market. Shorter-term returns have been volatile, with modest gains over one day and three months but notable declines over one month and year-to-date periods.

Implications for Investors

The Sell rating reflects a combination of average quality, fair valuation, negative financial trends, and sideways technicals. For investors, this rating signals caution. The company’s subdued growth, deteriorating profitability, and lacklustre price momentum suggest limited near-term upside. Investors with existing holdings may consider trimming exposure, while prospective buyers might wait for clearer signs of financial recovery or technical strength before entering.

Sector Context and Outlook

Operating in the pesticides and agrochemicals sector, Insecticides India Ltd faces competitive pressures and cyclical challenges. The sector’s performance is often linked to agricultural cycles, regulatory changes, and commodity price fluctuations. Given the company’s current financial and technical profile, it may struggle to capitalise on sectoral tailwinds without operational improvements or strategic initiatives to boost growth and profitability.

This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.

  • - Target price included
  • - Early movement detected
  • - Complete analysis ready

Get Complete Analysis Now →

Summary

Insecticides India Ltd’s current Sell rating by MarketsMOJO, last updated on 25 May 2026, is grounded in a thorough evaluation of the company’s fundamentals and market behaviour as of 09 July 2026. The stock’s average quality, fair valuation, negative financial trend, and sideways technical stance collectively suggest limited appeal for investors seeking growth or stability. The company’s recent quarterly results and underperformance relative to the market reinforce the cautious outlook. Investors should carefully weigh these factors when considering their portfolio allocations in the pesticides and agrochemicals sector.

Looking Ahead

For the rating to improve, Insecticides India Ltd would need to demonstrate a sustained turnaround in profitability, stronger sales growth, and positive technical momentum. Until such signals emerge, the Sell rating advises prudence. Monitoring quarterly earnings, sector developments, and price action will be essential for investors to reassess the stock’s prospects in the coming months.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News